SC 13D Filing

Company

NYMOX PHARMACEUTICAL CORP

Filed

January 30, 2004

Accession Number

0001132225-04-000002

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →